(Q43807574)

27 November 2017

title

Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection (English)

1 reference

27 November 2017

Kim D

1

1 reference

27 November 2017

Wang L

2

1 reference

27 November 2017

Caldwell CG

3

1 reference

27 November 2017

Chen P

4

1 reference

27 November 2017

Finke PE

5

1 reference

27 November 2017

Oates B

6

1 reference

27 November 2017

MacCoss M

7

1 reference

27 November 2017

Mills SG

8

1 reference

27 November 2017

Malkowitz L

9

1 reference

27 November 2017

Gould SL

10

1 reference

27 November 2017

DeMartino JA

11

1 reference

27 November 2017

Springer MS

12

1 reference

27 November 2017

Hazuda D

13

1 reference

27 November 2017

Miller M

14

1 reference

27 November 2017

Kessler J

15

1 reference

27 November 2017

Danzeisen R

16

1 reference

27 November 2017

Carver G

17

1 reference

27 November 2017

Carella A

18

1 reference

27 November 2017

Holmes K

19

1 reference

27 November 2017

Lineberger J

20

1 reference

27 November 2017

Schleif WA

21

1 reference

27 November 2017

Emini EA

22

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

27 November 2017

published in

1 reference

27 November 2017

volume

11

1 reference

27 November 2017

issue

24

1 reference

27 November 2017

page(s)

3103-3106

1 reference

Primary HIV-1 resistance: a new phase in the epidemic?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

HIV-1 entry - an expanding portal for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

Addition of Transiently-Generated Methyl o-Lithiobenzoate to Imines. An Isoindolone Annulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900655-2

7 January 2021

10.1016/S0960-894X(01)00655-2

Identifiers

DOI

1 reference

27 November 2017

1 reference